Related Experiment Video

Updated: Apr 19, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

37.5K

SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma

P Y Hernanda1,2, K Chen1,3, A M Das4

  • 1Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, Erasmus University Medical Center and Postgraduate School Molecular Medicine, Rotterdam, The Netherlands.

Oncogene
|December 23, 2014
PubMed

Insights

SMAD4, a known tumor suppressor, unexpectedly promotes hepatocellular carcinoma (HCC) growth by increasing nuclear levels in tumors. This finding suggests SMAD4 could predict patient outcomes and guide personalized HCC therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Hepatocellular carcinoma (HCC) pathogenesis requires further molecular understanding for effective therapies.
  • SMAD4 is a key mediator of transforming growth factor beta (TGFB) and bone morphogenetic protein (BMP) signaling, typically acting as a tumor suppressor.
  • The precise role of SMAD4 in HCC development and progression remains incompletely understood.

Purpose of the Study:

  • To investigate the role of SMAD4 in hepatocellular carcinoma (HCC).
  • To determine the clinical significance of SMAD4 expression and localization in HCC patients.
  • To explore the functional impact of SMAD4 on HCC cell behavior and tumor growth.

Main Methods:

  • Tissue microarray analysis of SMAD4 nuclear localization in 140 HCC patient tumors and adjacent tissues.
  • In vitro functional assays using HCC cell lines to assess colony formation and migration after SMAD4 knockdown.
  • In vivo studies in immune-deficient mice to evaluate the effect of SMAD4 knockdown on HCC tumor initiation and growth.
  • Analysis of SMAD4 signaling pathway activation (phosphorylated SMAD2/3 and SMAD1/5/8) and its correlation with patient outcomes.

Main Results:

  • Nuclear SMAD4 levels were significantly elevated in HCC tumors compared to adjacent tissues.
  • SMAD4 knockdown reduced HCC cell colony formation and migration in vitro.
  • SMAD4 knockdown inhibited HCC tumor initiation and growth in vivo.
  • Elevated nuclear SMAD4 and phosphorylated SMAD2/3 correlated with poor patient prognosis.
  • The canonical tumor-suppressive BMP signaling pathway mediated by SMAD4 was largely absent in HCC patients.

Conclusions:

  • SMAD4 exhibits a non-canonical, tumor-promoting function in a subset of HCC.
  • Elevated nuclear SMAD4 serves as a potential biomarker for predicting HCC patient outcomes.
  • Targeting SMAD4 may offer a novel strategy for personalized HCC therapeutic development.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K
In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K